SIC
NVAX icon

SJS Investment Consulting’s Novavax NVAX Stock Holding History

SJS Investment Consulting’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84K Buy
+301
New +$2.7K ﹤0.01% 1628

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

SJS Investment Consulting's NVAX Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Novavax (NVAX) in Q2 2026: 301 shares worth $2.84K. The stake represents ﹤0.01% of the portfolio and ranks #1628 among its holdings.

104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • SJS Investment Consulting held 301 shares of Novavax worth $2.84K as of Q2 2026.
  • Novavax was a new SJS Investment Consulting position in Q2 2026.
  • Novavax made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1628 holding.
  • 104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.